PCVX Exercise Disclosure
Guggenhime Andrew · SEC Form 4 · Filed Jul 6, 2026
Exercise
Calculated transaction value
$53.5K
Guggenhime Andrew President And CFO
PCVX
Vaxcyte
PCVX
Transaction date
Jul 6, 2026
Public filing date
Jul 6, 2026
Filing lag
Filed same day
PCVX daily price context
Close on/before transaction
$56.96
Jul 6, 2026
Close before public filing
$58.39
Jul 2, 2026
Return since public filing
+5.05%
Through Aug 20, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 10,000 shares @ $5.35
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001230724-26-000012
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$626.34K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vaxcyte, Inc. PCVX Current | Exercise | Jul 6, 2026 | $53.5K |
| Vaxcyte, Inc. PCVX | Sale | Jul 6, 2026 | $452.28K |
| Vaxcyte, Inc. PCVX | Sale | Jul 6, 2026 | $120.55K |
| Vaxcyte, Inc. PCVX | Exercise | Jul 6, 2026 | $0 |